These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22551713)

  • 21. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes.
    Fell DB; Sprague AE; Liu N; Yasseen AS; Wen SW; Smith G; Walker MC;
    Am J Public Health; 2012 Jun; 102(6):e33-40. PubMed ID: 22515877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study.
    Arnheim-Dahlström L; Hällgren J; Weibull CE; Sparén P
    BMJ; 2012 Dec; 345():e7594. PubMed ID: 23274350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic.
    Granath F; Gedeborg R; Smedje H; Feltelius N
    Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1045-1053. PubMed ID: 31062443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza.
    Chavant F; Ingrand I; Jonville-Bera AP; Plazanet C; Gras-Champel V; Lagarce L; Zenut M; Disson-Dautriche A; Logerot S; Auffret M; Coubret-Dumas A; Bruel ML; Boyer M; Bos-Thompson MA; Veyrac G; Carlier P; Beyens MN; Lates S; Damase-Michel C; Castot A; Kreft-Jaïs C; Pérault-Pochat MC
    Drug Saf; 2013 Jun; 36(6):455-65. PubMed ID: 23516007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.
    Chambers CD; Johnson D; Xu R; Luo Y; Louik C; Mitchell AA; Schatz M; Jones KL;
    Vaccine; 2013 Oct; 31(44):5026-32. PubMed ID: 24016809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.
    Ahmed SS; Schur PH; MacDonald NE; Steinman L
    J Autoimmun; 2014 May; 50():1-11. PubMed ID: 24559657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination against H1N1 influenza with Pandemrix(®) during pregnancy and delivery outcome: a Swedish register study.
    Källén B; Olausson PO
    BJOG; 2012 Dec; 119(13):1583-90. PubMed ID: 22901103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pandemic A/H1N1 influenza vaccination during pregnancy: a comparative study using the EFEMERIS database.
    Beau AB; Hurault-Delarue C; Vidal S; Guitard C; Vayssière C; Petiot D; Montastruc JL; Damase-Michel C; Lacroix I
    Vaccine; 2014 Mar; 32(11):1254-8. PubMed ID: 24486369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects.
    Romano CJ; Hall C; Khodr ZG; Bukowinski AT; Gumbs GR; Conlin AMS
    Vaccine; 2021 Oct; 39(44):6553-6562. PubMed ID: 34598819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low rate of pandemic A/H1N1 2009 influenza infection and lack of severe complication of vaccination in pregnant women: a prospective cohort study.
    Launay O; Krivine A; Charlier C; Truster V; Tsatsaris V; Lepercq J; Ville Y; Avenell C; Andrieu T; Rozenberg F; Artiguebielle F; Tréluyer JM; Goffinet F;
    PLoS One; 2012; 7(12):e52303. PubMed ID: 23300637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination.
    Fell DB; Wilson K; Ducharme R; Hawken S; Sprague AE; Kwong JC; Smith G; Wen SW; Walker MC
    PLoS One; 2016; 11(8):e0160342. PubMed ID: 27486858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early estimation of pandemic influenza Antiviral and Vaccine Effectiveness (EAVE): use of a unique community and laboratory national data-linked cohort study.
    Simpson CR; Lone N; McMenamin J; Gunson R; Robertson C; Ritchie LD; Sheikh A
    Health Technol Assess; 2015 Oct; 19(79):1-32. PubMed ID: 26450686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children.
    de Whalley P; Walker W; Snape MD; Oeser C; Casey M; Moulsdale P; Harrill C; Andrews N; Hoschler K; Thompson B; Jones C; Chalk J; Kerridge S; Tomlinson R; Heath PT; Finn A; Faust S; Miller E; Pollard AJ
    Health Technol Assess; 2011 Dec; 15(45):v-vi, xi-xiii, 1-128. PubMed ID: 22257497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study.
    Walsh LK; Donelle J; Dodds L; Hawken S; Wilson K; Benchimol EI; Chakraborty P; Guttmann A; Kwong JC; MacDonald NE; Ortiz JR; Sprague AE; Top KA; Walker MC; Wen SW; Fell DB
    BMJ; 2019 Jul; 366():l4151. PubMed ID: 31292120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study.
    Heikkinen T; Young J; van Beek E; Franke H; Verstraeten T; Weil JG; Della Cioppa G
    Am J Obstet Gynecol; 2012 Sep; 207(3):177.e1-8. PubMed ID: 22939717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.
    Eaton A; Lewis N; Fireman B; Hansen J; Baxter R; Gee J; Klein NP
    Vaccine; 2018 May; 36(19):2733-2739. PubMed ID: 28917536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns.
    Helmig RB; Maimburg RD; Erikstrup C; Nielsen HS; Petersen OB; Nielsen LP; Hvidman L; Veirum JE; Henriksen TB; Storgaard M
    Acta Obstet Gynecol Scand; 2015 Aug; 94(8):833-9. PubMed ID: 25958884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth.
    Richards JL; Hansen C; Bredfeldt C; Bednarczyk RA; Steinhoff MC; Adjaye-Gbewonyo D; Ault K; Gallagher M; Orenstein W; Davis RL; Omer SB
    Clin Infect Dis; 2013 May; 56(9):1216-22. PubMed ID: 23378281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.
    Dieleman J; Romio S; Johansen K; Weibel D; Bonhoeffer J; Sturkenboom M;
    BMJ; 2011 Jul; 343():d3908. PubMed ID: 21750072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.